These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38932820)

  • 1. Iran osteoporosis registry: protocol for nationwide study.
    Sanjari M; Fahimfar N; Mansourzadeh MJ; Khalagi K; Hesari E; Hajivalizadeh F; Namazi N; Sajjadi-Jazi SM; Mahmoudi M; Tanhaei M; Shirazi S; Larijani B; Ostovar A
    J Diabetes Metab Disord; 2024 Jun; 23(1):1387-1396. PubMed ID: 38932820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon kyphoplasty: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(12):1-45. PubMed ID: 23074451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density.
    Kadri A; Binkley N; Daffner SD; Anderson PA
    Spine J; 2022 Oct; 22(10):1634-1641. PubMed ID: 35680015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
    Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative bone health assessment and optimization in spine surgery.
    Anderson PA; Kadri A; Hare KJ; Binkley N
    Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?
    Hillier TA; Cauley JA; Rizzo JH; Pedula KL; Ensrud KE; Bauer DC; Lui LY; Vesco KK; Black DM; Donaldson MG; Leblanc ES; Cummings SR
    J Bone Miner Res; 2011 Aug; 26(8):1774-82. PubMed ID: 21351144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture risk assessment in celiac disease: a registry-based cohort study.
    Duerksen DR; Lix LM; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Leslie WD
    Osteoporos Int; 2021 Jan; 32(1):93-99. PubMed ID: 32748311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
    Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and baseline characteristics of a prospective cohort study for determinants of osteoporotic fracture in community-dwelling elderly Japanese men: the Fujiwara-kyo osteoporosis risk in men (FORMEN) study.
    Iki M; Fujita Y; Tamaki J; Kouda K; Yura A; Kadowaki E; Sato Y; Moon JS; Okamoto N; Kurumatani N;
    BMC Musculoskelet Disord; 2009 Dec; 10():165. PubMed ID: 20030855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated model of secondary fracture prevention in primary care (INTERCEPT): protocol for a cluster randomised controlled multicentre trial.
    Wang M; Knight A; Demeshko A; Girgis CM; Bolton P; Das A; Auwyang A; Williams B; Moses D; D'Este C; Seibel MJ
    BMC Prim Care; 2024 Sep; 25(1):349. PubMed ID: 39342106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.